Comparability of venous and capillary glucose measurements in blood

Diabetic Medicine

Volumn 20, Issue 11, 2003, Pages 953-956

  Colagiuri, Stephen ^a   Sandbaek A ^b   Carstensen, B ^c   Christensen, J ^c   Glumer, C ^c   Lauritzen, T ^b   Borch Johnsen, K ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b AARHUS UNIVERSITY   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

Blood glucose; Capillary; Comparability; Venous

Indexed keywords

ARTICLE; BLOOD GLUCOSE MONITORING; CAPILLARY BLOOD; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; ORAL GLUCOSE TOLERANCE TEST; VARIANCE; VENOUS BLOOD; ANALYSIS OF VARIANCE; CAPILLARY; COMPARATIVE STUDY; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; RANDOMIZATION; REGRESSION ANALYSIS; REPRODUCIBILITY; VEIN;

GLUCOSE;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CAPILLARIES; FASTING; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; RANDOM ALLOCATION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; VEINS;

EID: 1542498653     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01048.x     Document Type: Article

References (11)

1. Burrin JM, Alberti KGMM. What is blood glucose: can it be measured? Diabet Med 1990; 7: 199-206.
2. ADA. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
3. World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organisation Department of Noncommunicable Disease Surveillance, 1999; 1-59.
4. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttal BHR, Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obesity 2000; 24: S6-11.
5. Stahl M, Jorgensen LGM, Hyltoft Petersen P, Branslund I, de Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001; 61: 169-180.
6. Alpert NL. Report No. 14. Glucose analyzer and BUN analyzer. Laboratory World 1973; 24:40.
7. Pinheiro JC, Bates DM, eds. Mixed-effects Models in Sand S_PLUS. New York: Springer-Verlag, 2000.
8. Neely RDG, Kiwanuka JB, Hadden DR. Influence of sample type on the interpretation of the oral glucose tolerance test for gestational diabetes mellitus. Diabet Med 1991; 8: 129-134.
9. Farrer M, Fulcher G, Albers CJ, Neil HA, Adams PC, Alberti KG. Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year. Metabolism: Clin Exp 1995; 44: 1016-1027.
10. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clinica Chima Acta 2001; 307: 187-192.
11. Simmons D, Williams DRR. Random blood glucose as a screening test for diabetes in a biethnic population. Diabet Med 1994; 11: 830-835.